Does Anthem Cover Vyvanse?

At a glance
- Short answer / Anthem coverage varies by the exact plan and current formulary
- Search both names / "lisdexamfetamine" for generic and "Vyvanse" for brand
- Current California example / Generic Tier 2 with PA; brand Tier 3 with ST on the 2026 Individual Four Tier Select list
- Generic status / FDA approved multiple first generics in August 2023
- Cost / There is no reliable national Anthem copay; use the signed-in price tool
- Restrictions / PA, ST, dose optimization, and quantity limits can differ by product, strength, and plan
- Denial help / Read the pharmacy rejection or denial notice, then ask the prescriber and plan about PA, an exception, or an appeal
- FDA-approved uses / ADHD in patients age 6 and older; moderate-to-severe binge-eating disorder in adults
- Savings warning / Do not rely on old Vyvanse copay-card claims; Takeda's current Help At Hand product list does not include Vyvanse
The Accurate Answer Depends on Your Exact Anthem Plan
Anthem publishes many different formularies. The applicable list can vary by state, plan type, employer, funding arrangement, and benefit year. Anthem instructs members to select the state where the health plan is based, which may differ from the state where the member lives. It also advises members who are unsure which list applies to check with their employer or call Pharmacy Member Services on the ID card [1].
That is why statements such as "most Anthem plans cover Vyvanse," "Anthem always requires prior authorization," or "your copay will be $30 to $75" are not dependable. A drug can be:
- covered without a special restriction;
- covered only after prior authorization;
- subject to step therapy, dose optimization, or a quantity limit;
- covered at a different tier in brand and generic form; or
- excluded under a particular benefit design.
Even a public Anthem formulary warns that a listed drug may not be covered under every plan design using that list. The member's Evidence of Coverage, Summary Plan Description, and signed-in pharmacy benefit remain controlling [2].
How to Check Anthem Coverage for Vyvanse
Use this process before relying on a price estimate or asking a prescriber to change treatment:
- Sign in to Anthem or the Sydney Health app so the pharmacy tool can connect to your actual benefit.
- Open the drug-list or prescription section.
- Search lisdexamfetamine dimesylate and Vyvanse separately. Brand and generic can have different tiers and restrictions.
- Match the dosage form and strength. Vyvanse is available as capsules and chewable tablets, and restrictions can differ by form or strength.
- Read the formulary codes. Common codes include PA for prior authorization, ST for step therapy, QL for quantity limit, and DO for dose optimization.
- Use the signed-in price tool with the intended pharmacy. A tier alone does not reveal the member's final cost.
- If anything is unclear, call the Pharmacy Member Services number on the ID card and ask for the result to be explained against the exact plan.
Anthem's public member page confirms that its signed-in tools can show the current plan drug list and medication costs. It also explains that the Notes column identifies prior authorization or step-therapy requirements [3].
A Current 2026 Anthem Formulary Example
Anthem's 2026 California Individual Four Tier Select Drug List, last updated and effective July 1, 2026, provides a useful example of how brand and generic coverage can differ [2]:
- Generic lisdexamfetamine capsules and chewable tablets are listed on Tier 2.
- The generic entries carry prior authorization plus either dose-optimization or quantity-limit rules, depending on strength.
- Brand-name Vyvanse capsules and chewable tablets are listed on Tier 3.
- The brand entries carry step therapy plus either dose-optimization or quantity-limit rules, depending on strength.
This example answers what one current Anthem plan family does. It does not establish a nationwide Anthem policy, a guaranteed approval, or a specific copay. Anthem publishes separate Essential, National, Select, Medicare, Medicaid, and employer-related lists, and those lists can change.
What Prior Authorization and Step Therapy Mean
Prior authorization means the plan asks for information before it decides whether the prescription qualifies for coverage. The exact documentation depends on the plan's current criteria. It may include the diagnosis, requested product and strength, treatment history, reasons alternatives are unsuitable, and relevant clinical records.
Step therapy means the plan may require one or more preferred treatments to be tried before it covers the requested drug. A formulary code by itself does not tell you:
- which alternatives count;
- how long a prior trial must have lasted;
- whether a previous trial under another insurer counts;
- whether a contraindication or adverse reaction supports an exception; or
- which diagnosis-specific criteria apply.
Do not invent a 30-, 60-, or 90-day trial requirement. Ask Anthem for the criteria tied to the member's plan and request. A prescriber can generally initiate pharmacy prior authorization electronically; Anthem identifies electronic prior authorization as its preferred submission method [4].
What Vyvanse Costs With Anthem
There is no accurate national Anthem price for Vyvanse or generic lisdexamfetamine. The member's amount can change with:
- brand versus generic;
- formulary tier;
- remaining deductible;
- copay versus coinsurance;
- pharmacy network level;
- dosage form and strength;
- quantity and days' supply; and
- an approved or denied coverage restriction.
The best estimate is the authenticated price shown for the member's exact drug, strength, quantity, and pharmacy. Confirm the amount with the pharmacy before pickup, especially after a formulary or benefit-year change.
A cash discount can sometimes be lower than an insurance claim, but it is a separate transaction. Ask whether the purchase would count toward the plan deductible or out-of-pocket limit before choosing it.
Do Not Rely on an Old Vyvanse Copay-Card Claim
Older pages may describe a U.S. Takeda Vyvanse savings card or say the cost can be reduced to a fixed amount. That is not a safe current claim. Takeda's Help At Hand site lists its eligible medicines as of 2026, and Vyvanse is not on that list [5]. Program availability and eligibility can change, so verify assistance only through a current manufacturer source before depending on it.
What to Do If Anthem Rejects or Denies the Prescription
First determine what happened. A pharmacy claim rejection is not always a final coverage denial. The message may identify a missing prior authorization, step-therapy requirement, quantity limit, refill timing issue, non-formulary status, or pharmacy-network problem.
Use the following sequence:
- Ask the pharmacy for the exact rejection message.
- Call Pharmacy Member Services and ask which restriction or exclusion applied.
- Ask whether generic lisdexamfetamine and brand Vyvanse have different coverage.
- Give the prescriber the plan's current criteria or prior-authorization instructions.
- If the request is denied, read the written notice for the reason, filing method, deadline, and expedited-review rules.
- Submit the specific records that address the stated reason. More paperwork is not automatically better; relevant documentation is.
Commercial, Medicaid, and Medicare appeal procedures are not interchangeable. Follow the denial notice and the plan's Evidence of Coverage rather than a generic internet deadline.
For Medicare Part D, CMS says a standard coverage determination for a benefit must generally be issued within 72 hours and an expedited determination within 24 hours. For an exception request, the clock starts when the plan receives the prescriber's supporting statement. The current 2026 CMS flowchart gives 65 days to request the first appeal and seven days for a standard redetermination of a benefit [6]. These federal Part D timeframes should not be presented as rules for every commercial Anthem plan.
FDA Status and Clinical Evidence
The current FDA labeling states that Vyvanse is indicated for:
- attention-deficit/hyperactivity disorder in adults and pediatric patients age 6 and older; and
- moderate-to-severe binge-eating disorder in adults.
The label also states that Vyvanse is not indicated for weight loss. It is a Schedule II controlled substance and carries a boxed warning about abuse, misuse, and addiction [7].
FDA approved multiple first generics of lisdexamfetamine capsules and chewable tablets in August 2023. FDA's 2023 Office of Generic Drugs report identifies ADHD in patients age 6 and older and moderate-to-severe binge-eating disorder in adults as the referenced indications [8].
Peer-reviewed evidence supports lisdexamfetamine's efficacy for its approved uses. A systematic review and meta-analysis evaluated lisdexamfetamine and other medicines for adult ADHD [9]. Two phase 3 randomized controlled trials evaluated lisdexamfetamine in adults with moderate-to-severe binge-eating disorder [10]. Clinical evidence can support a prescriber's rationale, but it does not guarantee that a particular Anthem plan will approve a request.
Questions to Ask Anthem
Use precise questions so the answer is tied to the correct benefit:
- Is generic lisdexamfetamine covered under my current pharmacy benefit?
- Is brand-name Vyvanse covered separately?
- What tier applies to this dosage form and strength?
- Does PA, ST, QL, or DO apply?
- Where can my prescriber find the current criteria?
- What alternatives satisfy step therapy, if any?
- Is an exception available when a preferred drug is ineffective, not tolerated, or contraindicated?
- What will I pay at this specific pharmacy after my current deductible?
- If the request is denied, what is the appeal deadline and how is an expedited review requested?
Document the date, representative, and reference number for the call. Formularies and benefit details can change, so save the current drug-list page and any written decision.
Frequently asked questions
Does Anthem cover Vyvanse?
Does Anthem cover generic Vyvanse?
Does Anthem require prior authorization for Vyvanse?
How much is Vyvanse with Anthem insurance?
Why should I search both Vyvanse and lisdexamfetamine?
What do PA, ST, QL, and DO mean?
How long does Anthem take to decide a prior authorization?
Can I appeal an Anthem denial for Vyvanse?
Is Vyvanse FDA approved for binge-eating disorder?
Is there a current Takeda Vyvanse copay card?
References
- Anthem. Drug List: The Prescription Drugs Your Plan Covers. https://www.anthem.com/pharmacy-information/drug-list-formulary
- Anthem Blue Cross. 2026 California Individual Four Tier Select Drug List. Effective July 1, 2026. https://fm.formularynavigator.com/FBO/143/2026_Select_4_Tier_CA_IND.pdf
- Anthem. Member Pharmacy Benefits. https://www.anthem.com/pharmacy-information/for-members
- Anthem. Pharmacy for Individual and Commercial Plans: Prior Authorization Process. https://www.anthem.com/provider/individual-commercial/pharmacy
- Takeda Help At Hand. Medicines Available Through Takeda Help At Hand. https://www.helpathandpap.com/Products.aspx
- Centers for Medicare & Medicaid Services. Medicare Prescription Drug (Part D) Coverage Determination and Appeals Process. 2026. https://www.cms.gov/medicare/appeals-and-grievances/medprescriptdrugapplgriev/downloads/flowchart-medicare-part-d.pdf
- DailyMed. Vyvanse (lisdexamfetamine dimesylate) Prescribing Information. Updated April 2026. https://dailymed.nlm.nih.gov/dailymed/drugInfo.cfm?setid=704e4378-ca83-445c-8b45-3cfa51c1ecad
- U.S. Food and Drug Administration. Office of Generic Drugs 2023 Annual Report. https://www.fda.gov/media/176440/download
- Stuhec M, Lukić P, Locatelli I. Efficacy, Acceptability, and Tolerability of Lisdexamfetamine, Mixed Amphetamine Salts, Methylphenidate, and Modafinil in the Treatment of Attention-Deficit Hyperactivity Disorder in Adults: A Systematic Review and Meta-analysis. Ann Pharmacother. 2019;53(2):121-133. https://pubmed.ncbi.nlm.nih.gov/30117329/
- McElroy SL, et al. Lisdexamfetamine dimesylate for adults with moderate to severe binge eating disorder: results of two phase 3 randomized controlled trials. Neuropsychopharmacology. 2016;41(5):1251-1260. https://pubmed.ncbi.nlm.nih.gov/26346638/